Moreover, we demonstrated elevated AEA levels in FAAH-deficiency irrespective of treatment with GW6471 or its vehicle DMSO, indicating that PPAR-α antagonism did not affect production or degradation of AEA. The gene discussed is PPARA; the disease is hyperinsulinemic hypoglycemia, familial, 4.